Clinical course · draft
Chelation therapy
A draft clinical course on chelation therapy: what it is, the evidence status, indications, safety, adverse events and consent, with sources. Includes onsite training, half a day.
Curriculum
Understanding the treatment
- What it is and the evidence statusReading
- Recognised indicationsReading
Delivering safely
- Contraindications and pre-treatment checksReading
- Safety protocol and monitoringReading
- Adverse events and escalationReading
- Consent pointsReading
Onsite training
- Onsite trainingOnsite
References
- SourcesReading · free preview
References
Sources
- American College of Medical Toxicology. ACMT recommends against use of post-chelator challenge urinary metal testing. J Med Toxicol. 2017.
- Lamas GA et al. Edetate disodium-based chelation for patients with a previous myocardial infarction and diabetes: TACT2 randomized clinical trial. JAMA. 2024.
- CDC. Deaths associated with hypocalcemia from chelation therapy: Texas, Pennsylvania and Oregon, 2003 to 2005. MMWR. 2006;55(8).
- FDA. Questions and answers on unapproved chelation products.
- FDA prescribing information: succimer (Chemet).
- FDA prescribing information: edetate calcium disodium.